Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1 Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Holger Lembrér, was filed 02 Dec 2024.
Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1: what insiders have been doing
Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1 is a listed company. Its directors and officers file their transactions with Finansinspektionen. Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1 has had no insider filing for more than a year; the last one goes back to 2 December 2024.
Since 2017, the database holds 32 purchases and 4 sales by insiders of the company.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
- 20,000 shares@ SEK 7.76100.0% of flowAktieISIN SE0011231158FI:csv-78ef3b27ae33f9a8bb0eCanonical exit: 27 Feb 2025 (T+90)
- 650,000 shares@ SEK 6.92100.0% of flowAktieISIN SE0011231158FI:csv-cdb2c9711607e5bfb888Canonical exit: 25 Feb 2025 (T+90)
- 900,000 shares@ SEK 7.1289.6% of flowAktieISIN SE0011231158FI:csv-aa3a34fa4725294adad8Canonical exit: 28 Jan 2025 (T+90)
- 65,000 shares@ SEK 7.126.5% of flowAktieISIN SE0011231158FI:csv-23324ae79b27f1588c3bCanonical exit: 28 Jan 2025 (T+90)
- 900,000 shares@ SEK 7.12100.0% of flowAktieISIN SE0011231158FI:csv-cbb63eaa4140796b0db3Canonical exit: 28 Jan 2025 (T+90)
- 100,000 shares@ SEK 7.1274.9% of flowAktieISIN SE0011231158FI:csv-141b3a537fde9c1b64d9Canonical exit: 28 Jan 2025 (T+90)
- 5,000 shares@ SEK 10.805.8% of flowAktieISIN SE0011231158FI:csv-59bf10886f873b322171Canonical exit: 13 Aug 2023 (T+90)
- 10,000 shares@ SEK 12.0012.8% of flowAktieISIN SE0011231158FI:csv-b980c1d6a05a25081f3eCanonical exit: 1 Aug 2023 (T+90)
- 5,000 shares@ SEK 12.006.4% of flowAktieISIN SE0011231158FI:csv-195065678bbc673ff746Canonical exit: 2 Jul 2023 (T+90)
- 8,000 shares@ SEK 12.75100.0% of flowAktieISIN SE0011231158FI:csv-50da45f87e8c7e8f7e08Canonical exit: 28 May 2023 (T+90)
- 7,083 shares@ SEK 14.1529.5% of flowAktieISIN SE0011231158FI:csv-6b8ac9ddef8b384c8d88Canonical exit: 4 May 2023 (T+90)
- 17,288 shares@ SEK 12.9315.5% of flowAktieISIN SE0011231158FI:csv-3fe3eab27081c4457c38Canonical exit: 14 Mar 2023 (T+90)
- 55,034 shares@ SEK 12.8348.9% of flowAktieISIN SE0011231158FI:csv-95f1daa4a884c28f5fceCanonical exit: 15 Mar 2023 (T+90)
- 2,678 shares@ SEK 12.952.4% of flowAktieISIN SE0011231158FI:csv-b0aefb50f5de6c3b6282Canonical exit: 16 Mar 2023 (T+90)
- 1,940 shares@ SEK 7.701.0% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-740a3013004bee2d4b37
- 1,021 shares@ SEK 7.700.1% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-dcaba7acf1e787d56782Canonical exit: 28 Feb 2023 (T+90)
- 851,916 shares@ SEK 7.7093.6% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-b4f0a21f520665387812
- 57,969 shares@ SEK 7.706.4% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-e5ea935cabc104fa42bd
- 490 shares@ SEK 7.704.3% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-558ab97f70841d0554b9
- 817 shares@ SEK 7.701.9% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-627e521285e126a41c9fCanonical exit: 28 Feb 2023 (T+90)
- 10,650 shares@ SEK 7.70100.0% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-958862a35f47ebbcdd78
- 2,000 shares@ SEK 7.7050.2% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-654cd036503f4c1f10d9
- 2,000 shares@ SEK 7.7049.8% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-b2434c08970ea3a44325
- 250 shares@ SEK 7.708.4% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-15ae2e7d0d0a92e0fc15
- 15,000 shares@ SEK 7.701.7% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-9f9010d1033aebd862e3Canonical exit: 26 Feb 2023 (T+90)
25 of 51 declarations
About Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1
Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1 is a stock option program associated with Boule Diagnostics AB, a company specializing in medical diagnostics. The program is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations